Category: Home

Lower body fat distribution

Lower body fat distribution

Published : 16 March In younger men, androgens are produced at high levels distibution the testes. Download PDF.

Lower body fat distribution -

Wegner L, Andersen G, Sparsø T et al Common variation in LMNA increases susceptibility to type 2 diabetes and associates with elevated fasting glycemia and estimates of body fat and height in the general population: studies of 7, Danish Whites. Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJ, Anderson CM Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians.

Physiol Genomics — Arterioscler Thromb Vasc Biol — Toy BR Familial multiple lipomatosis. Dermatol Online J Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den BH, Van de Ven WJ Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours.

Markowski DN, Thies HW, Gottlieb A, Wenk H, Wischnewsky M, Bullerdiek J HMGA2 expression in white adipose tissue linking cellular senescence with diabetes.

Genes Nutr — Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A Role of the high mobility group A proteins in human lipomas.

Carcinogenesis — Battista S, Fidanza V, Fedele M et al The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis.

Cancer Res — Zhou X, Benson KF, Ashar HR, Chada K Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C.

Pasquali D, Pierantoni GM, Fusco A et al Fenofibrate increases the expression of high mobility group AT-hook 2 HMGA2 gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy.

J Mol Endocrinol — Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.

Pouliot MC, Despres JP, Dionne FT et al ApoB gene EcoRI polymorphism. Relations to plasma lipoprotein changes associated with abdominal visceral obesity. Arterioscler Thromb — Rebuffe-Scrive M, Lundholm K, Bjorntorp P Glucocorticoid hormone binding to human adipose tissue.

Eur J Clin Invest — Fried SK, Russell CD, Grauso NL, Brolin RE Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.

Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Kloting N, Graham TE, Berndt J et al Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.

Cell Metab — Montague CT, Prins JB, Sanders L et al Depot-related gene expression in human subcutaneous and omental adipocytes. Fried SK, Bunkin DA, Greenberg AS Omental and subcutaneous adipose tissues of obese subjects release interleukin depot difference and regulation by glucocorticoid.

Lefebvre AM, Laville M, Vega N et al Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Parikh H, Groop L Candidate genes for type 2 diabetes.

Rev Endocr Metab Disord — Bottcher Y, Unbehauen H, Kloting N et al Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene BMPR1A are associated with human obesity. Kovacs P, Geyer M, Berndt J et al Effects of genetic variation in the human retinol binding protein-4 gene RBP4 on insulin resistance and fat depot-specific mRNA expression.

Schleinitz D, Kloting N, Korner A et al Effect of genetic variation in the human fatty acid synthase gene FASN on obesity and fat depot-specific mRNA expression.

Obesity — Schleinitz D, Kloting N, Bottcher Y et al Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 BMPR2 in the pathophysiology of obesity. PLoS One 6:e Yang X, Smith U Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?

Kodama N, Tahara N, Tahara A et al Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus. J Clin Endocrinol Metab 98 11 — Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR Obesity associated with a mutation in a genetic regulator of adipocyte differentiation.

Passaro A, Dalla NE, Marcello C et al PPARgamma Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome. Cardiovasc Diabetol Kim KS, Choi SM, Shin SU, Yang HS, Yoon Y Effects of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism on body fat distribution in female Korean subjects.

Peeters AV, Beckers S, Verrijken A et al Association of SIRT1 gene variation with visceral obesity. Hum Genet — Chambers JC, Elliott P, Zabaneh D et al Common genetic variation near MC4R is associated with waist circumference and insulin resistance.

Heard-Costa NL, Zillikens MC, Monda KL et al NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet 5:e Speliotes EK, Willer CJ, Berndt SI et al Association analyses of , individuals reveal 18 new loci associated with body mass index.

Nat Genet —U Lindgren CM, Heid IM, Randall JC et al Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution. Berndt SI, Gustafsson S, Magi R et al Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.

Norris JM, Langefeld CD, Talbert ME et al Genome-wide association study and follow-up analysis of adiposity traits in Hispanic Americans: the IRAS Family Study. Fox CS, Liu Y, White CC et al Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.

PLoS Genet 8:e Liu CT, Monda KL, Taylor KC et al Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet 9:e Hotta K, Kitamoto A, Kitamoto T et al Replication study of 15 recently published loci for body fat distribution in the Japanese population.

J Atheroscler Thromb — Fox CS, White CC, Lohman K et al Genome-wide association of pericardial fat identifies a unique locus for ectopic fat. Randall JC, Winkler TW, Kutalik Z et al Sex-stratified genome-wide association studies including , individuals show sexual dimorphism in genetic loci for anthropometric traits.

Zillikens MC, Yazdanpanah M, Pardo LM et al Sex-specific genetic effects influence variation in body composition. Shmueli O, Horn-Saban S, Chalifa-Caspi V et al GeneNote: whole genome expression profiles in normal human tissues.

C R Biol — Sandholt CH, Hansen T, Pedersen O Beyond the fourth wave of genome-wide obesity association studies. Nutr Diabetes 2:e Schleinitz D, Kloting N, Lindgren CM et al Fat depot-specific mRNA expression of novel loci associated with waist-hip ratio.

Int J Obes 38 1 — Cooney GJ, Lyons RJ, Crew AJ et al Improved glucose homeostasis and enhanced insulin signalling in Grbdeficient mice.

EMBO J — Cariou B, Capitaine N, Le MV et al Increased adipose tissue expression of Grb14 in several models of insulin resistance. FASEB J — Holt LJ, Lyons RJ, Ryan AS et al Dual ablation of Grb10 and Grb14 in mice reveals their combined role in regulation of insulin signaling and glucose homeostasis.

Mol Endocrinol — Gesta S, Bluher M, Yamamoto Y et al Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A — Tchkonia T, Lenburg M, Thomou T et al Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns.

Gesta S, Tseng YH, Kahn CR Developmental origin of fat: tracking obesity to its source. Cell — Karastergiou K, Fried SK, Xie H et al Distinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots.

Yamamoto Y, Gesta S, Lee KY, Tran TT, Saadatirad P, Kahn CR Adipose depots possess unique developmental gene signatures.

Lee KY, Yamamoto Y, Boucher J et al Shox2 is a molecular determinant of depot-specific adipocyte function. Plagemann A Perinatal programming and functional teratogenesis: impact on body weight regulation and obesity. Physiol Behav — Blumfield ML, Hure AJ, MacDonald-Wicks LK et al Dietary balance during pregnancy is associated with fetal adiposity and fat distribution.

Caserta F, Tchkonia T, Civelek VN et al Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes. Pinnick KE, Karpe F DNA methylation of genes in adipose tissue. Proc Nutr Soc — Sakamoto H, Suzuki M, Abe T et al Cell type-specific methylation profiles occurring disproportionately in CpG-less regions that delineate developmental similarity.

Genes Cells — Li M, Wu H, Wang T et al Co-methylated genes in different adipose depots of pig are associated with metabolic, inflammatory and immune processes. Int J Biol Sci — Clin Epigenetics Marchi M, Lisi S, Curcio M et al Human leptin tissue distribution, but not weight loss-dependent change in expression, is associated with methylation of its promoter.

Epigenetics — Genome Res — Download references. DS is funded by the Boehringer Ingelheim Foundation. YB and PK are supported by the IFB AdiposityDiseases K50D and K to YB; K and K to PK. IFB AdiposityDiseases is funded by the Federal Ministry of Education and Research BMBF , Germany, FKZ: 01EO DS, YB, MB and PK were responsible for the conception and design of the manuscript, drafting the manuscript, revising it critically for intellectual content and approving the final version.

Integrated Research and Treatment Center IFB AdiposityDiseases, University of Leipzig, Liebigstr. Department of Medicine, University of Leipzig, Leipzig, Germany. You can also search for this author in PubMed Google Scholar.

Correspondence to Peter Kovacs. Reprints and permissions. Schleinitz, D. et al. The genetics of fat distribution. Diabetologia 57 , — Download citation.

Received : 01 November Accepted : 18 February Published : 16 March Issue Date : July Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative.

Download PDF. Abstract Fat stored in visceral depots makes obese individuals more prone to complications than subcutaneous fat. The Definition and Prevalence of Obesity and Metabolic Syndrome Chapter © Why are South Asians prone to type 2 diabetes?

A hypothesis based on underexplored pathways Article 31 March The Barker Hypothesis Chapter © Use our pre-submission checklist Avoid common mistakes on your manuscript. Introduction Obesity increases the individual risk for type 2 diabetes, dyslipidaemia, fatty liver disease, hypertension and cardiovascular disease [ 1 ].

Measurement of fat distribution In clinical practice, waist circumference WC and WHR are widely used variables used to determine regional FD. Which factors determine fat distribution? Full size image. Genetic background of fat distribution There is good evidence that not only obesity but also FD is controlled by genetic factors, and that this is independent of BMI and overall obesity [ 26 , 27 ].

Conditions of altered fat distribution Conditions such as steatopygia and lipodystrophies also support the role of genetics in FD. Candidate genes for regulating fat distribution The classical approach to examining the heterogeneity of adipose tissue is based on comparisons of protein and gene function and expression between the visceral and subcutaneous fat depots.

Developmental genes in the regulation of fat distribution Fat depot-specific expression of developmental genes provides further support for the strong genetic background of FD [ 92 ].

Epigenetics and other aspects It should be noted that, despite recent advances in the field of high-throughput genetic analyses resulting in a number of novel polymorphisms associated with WHR, these polymorphisms can only explain a small proportion of phenotypic variance and genetic heritability in FD [ 30 ].

Closing remarks Undoubtedly, and regardless of forms of altered FD, fat deposition is strongly determined by genetic factors. Abbreviations CT: Computerised tomography eQTL: Expression quantitative trait locus FD: Fat distribution GWAS: Genome-wide association studies SNP: Single nucleotide polymorphism WC: Waist circumference.

References Van Gaal LF, Mertens IL, De Block CE Mechanisms linking obesity with cardiovascular disease. Nature — PubMed Google Scholar Reaven GM Importance of identifying the overweight patient who will benefit the most by losing weight.

Ann Intern Med — PubMed Google Scholar Kloting N, Fasshauer M, Dietrich A et al Insulin-sensitive obesity. Am J Physiol Endocrinol Metab E—E PubMed Google Scholar Stefan N, Kantartzis K, Machann J et al Identification and characterization of metabolically benign obesity in humans.

Arch Intern Med — PubMed Google Scholar Kissebah AH Central obesity: measurement and metabolic effects. Diabetes Rev —20 Google Scholar Bjorntorp P Metabolic implications of body-fat distribution. Diabetes Care — CAS PubMed Google Scholar Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Tokunaga K Pathophysiology and pathogenesis of visceral fat obesity.

Ann N Y Acad Sci — CAS PubMed Google Scholar Despres JP, Nadeau A, Tremblay A et al Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes — CAS PubMed Google Scholar Klein S, Fontana L, Young VL et al Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.

N Engl J Med — CAS PubMed Google Scholar Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding.

Int J Obes Relat Metab Disord — CAS PubMed Google Scholar Wajchenberg BL Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.

Endocr Rev — CAS PubMed Google Scholar Bluher M Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes — CAS PubMed Google Scholar Speliotes EK, Massaro JM, Hoffmann U et al Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.

Hepatology — CAS PubMed Central PubMed Google Scholar Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension — CAS PubMed Central PubMed Google Scholar Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

Metabolism —59 CAS PubMed Google Scholar Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despres JP A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr — CAS PubMed Google Scholar Lemieux I, Pascot A, Couillard C et al Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad hyperinsulinemia; hyperapolipoprotein B; small, dense LDL in men?

Circulation — CAS PubMed Google Scholar Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U Impact of obesity on metabolism in men and women. J Clin Invest — CAS PubMed Central PubMed Google Scholar Goss AM, Darnell BE, Brown MA, Oster RA, Gower BA Longitudinal associations of the endocrine environment on fat partitioning in postmenopausal women.

Obesity Silver Spring — CAS Google Scholar Seidell JC, Bjorntorp P, Sjostrom L, Kvist H, Sannerstedt R Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels.

Metabolism — CAS PubMed Google Scholar Bouchard C, Tremblay A, Despres JP et al The response to long-term overfeeding in identical twins. N Engl J Med — CAS PubMed Google Scholar Smith SR, Zachwieja JJ Visceral adipose tissue: a critical review of intervention strategies. Int J Obes Relat Metab Disord — CAS PubMed Google Scholar Ronn M, Kullberg J, Karlsson H et al Bisphenol A exposure increases liver fat in juvenile fructose-fed Fischer rats.

Toxicology — PubMed Google Scholar Malik VS, Popkin BM, Bray GA, Despres JP, Hu FB Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation — PubMed Central PubMed Google Scholar Bjorntorp P Do stress reactions cause abdominal obesity and comorbidities?

Liposuction is a type of cosmetic surgery that breaks up and sucks fat from the body. It is not a weight-loss procedure; the results are purely…. Mesenteric panniculitis is a rare disorder that affects the abdomen, causing pain and other symptoms.

Learn more about the diagnosis and treatment. Conditions that can cause muscle wasting include muscular dystrophy, multiple sclerosis, and spinal muscular atrophy. Treatment may include dietary…. The most healthful diet involves eating a variety of nutrient dense foods from all major food groups.

Learn about healthful diets and tips here. A person can manage their diabetes by making healthful changes to their diet, exercising frequently, and regularly taking the necessary medications….

My podcast changed me Can 'biological race' explain disparities in health? Why Parkinson's research is zooming in on the gut Tools General Health Drugs A-Z Health Hubs Health Tools Find a Doctor BMI Calculators and Charts Blood Pressure Chart: Ranges and Guide Breast Cancer: Self-Examination Guide Sleep Calculator Quizzes RA Myths vs Facts Type 2 Diabetes: Managing Blood Sugar Ankylosing Spondylitis Pain: Fact or Fiction Connect About Medical News Today Who We Are Our Editorial Process Content Integrity Conscious Language Newsletters Sign Up Follow Us.

Medical News Today. Health Conditions Health Products Discover Tools Connect. Lipodystrophy: Identification, types, and diagnosis.

Medically reviewed by Angelica Balingit, MD — By Jesse Klein and Charlotte Lillis — Updated on February 16, Pictures What is it? Symptoms Types Causes Risk factors Diagnosis Treatment Outlook FAQs Summary Lipodystrophy is a rare disorder that affects how the body accumulates and stores fat.

What is lipodystrophy? Symptoms of lipodystrophy. Types of lipodystrophy. Causes of lipodystrophy. Gene Unique features AGPAT2 loss of metabolically active fat BSCL2 generalized absence of all fat tissue CAV1 short stature, vitamin D resistance, low blood calcium and low blood magnesium levels PTRF muscle weakness and skeletal irregularities, gastrointestinal problems and irregularities, and cardiac arrhythmias.

Risk factors. Diagnosis of lipodystrophy. Treatment of lipodystrophy. Frequently asked questions. How we reviewed this article: Sources.

Medical News Today has strict sourcing guidelines and draws only from peer-reviewed studies, academic research institutions, and medical journals and associations. We avoid using tertiary references.

We link primary sources — including studies, scientific references, and statistics — within each article and also list them in the resources section at the bottom of our articles. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.

Share this article. Latest news Ovarian tissue freezing may help delay, and even prevent menopause. RSV vaccine errors in babies, pregnant people: Should you be worried?

Scientists discover biological mechanism of hearing loss caused by loud noise — and find a way to prevent it. How gastric bypass surgery can help with type 2 diabetes remission. Atlantic diet may help prevent metabolic syndrome. Related Coverage.

What are the benefits and risks of liposuction? Medically reviewed by University of Illinois. What is mesenteric panniculitis? There are several possible explanations for the observed association between excess visceral fat accumulation and the metabolic syndrome.

Visceral fat is thought to release fatty acids into the portal circulation, where they may cause insulin resistance in the liver and subsequently in muscle. A parallel hypothesis is that adipose tissue is an endocrine organ that secretes a variety of endocrine hormones such as leptin, interleukin 6, angiotensin II, adiponectin, and resistin, which may have potent effects on the metabolism of peripheral tissues.

In conclusion, excess accumulation of either visceral abdominal or muscle AT is associated with a higher prevalence of metabolic syndrome in older adults, particularly in those who are of normal body weight. This suggests that practitioners should not discount the risk of metabolic syndrome in their older patients entirely on the basis of body weight or BMI.

Indeed, generalized body composition, in terms of both BMI and the proportion of body fat, does not clearly distinguish older subjects with the metabolic syndrome. Moreover, racial differences in the various components of the metabolic syndrome provide strong evidence that the cause of the syndrome likely varies in blacks and whites.

Thus, the development of a treatment for the metabolic syndrome as a unifying disorder is likely to be complex. Correspondence: Bret H. Goodpaster, PhD, Department of Medicine, North MUH, University of Pittsburgh Medical Center, Pittsburgh, PA bgood pitt. Dr Goodpaster was supported by grant KAG from the National Institute on Aging, National Institutes of Health.

full text icon Full Text. Download PDF Top of Article Abstract Methods Results Comment Article Information References. Figure 1. View Large Download. Table 1. Characteristics of Men and Women With and Without Metabolic Syndrome. Regional Fat Distribution According to Metabolic Syndrome Status.

Abdominal AT in Men and Women With and Without Metabolic Syndrome According to a Revised Definition Omitting Waist Circumference.

Haffner SValdez RHazuda HMitchell BMorales PStern M Prospective analysis of the insulin resistance syndrome syndrome X. Diabetes ; PubMed Google Scholar Crossref. Isomaa BAlmgren PTuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Diabetes Care ; PubMed Google Scholar Crossref. National Institutes of Health, Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults Adult Treatment Panel III. Bethesda, Md National Institutes of Health;NIH publication Ford EGiles WDietz W Prevalence of the metabolic syndrome among US adults.

JAMA ; PubMed Google Scholar Crossref. Grundy SMHansen BSmith SC Jr et al. Circulation ; PubMed Google Scholar Crossref. Harris MIFlegal KMCowie CC et al.

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U. adults: the Third National Health and Nutrition Examination Survey, Resnick HEHarris MIBrock DBHarris TB American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey.

Wilson PWEvans JC Coronary artery disease prediction. Am J Hypertens ;S- S PubMed Google Scholar Crossref. Mokdad AHBowman BAFord ESVinicor FMarks JSKoplan JP The continuing epidemics of obesity and diabetes in the United States.

Després JNadeau ATremblay A et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Goodpaster BHThaete FLSimoneau J-AKelley DE Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.

Kelley DEThaete FLTroost FHuwe TGoodpaster BH Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance.

Am J Physiol Endocrinol Metab ;E E PubMed Google Scholar. Goodpaster BKrishnaswami SResnick H et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women.

Seidell JCOosterlee AThijssen MA et al. Assessment of intra-abdominal and subcutaneous abdominal fat: relation between anthropometry and computed tomography. Am J Clin Nutr ; 13 PubMed Google Scholar. Goodpaster BHKelley DEThaete FLHe JRoss R Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content.

J Appl Physiol ; PubMed Google Scholar. Brach JSSimonsick EMKritchevsky SYaffe KNewman AB The association between physical function and lifestyle activity and exercise in the Health, Aging and Body Composition Study.

J Am Geriatr Soc ; PubMed Google Scholar Crossref. Van Pelt REEvans EMSchechtman KBEhsani AAKohrt WM Contributions of total and regional fat mass to risk for cardiovascular disease in older women.

Albu JBMurphy LFrager DHJohnson JAPi-Sunyer FX Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Mandavilli ACyranoski D Asia's big problem.

Nat Med ; PubMed Google Scholar Crossref. DeNino WFTchernof ADionne IJ et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women.

Després J-P Abdominal obesity as important component of insulin resistance syndrome. Nutrition ; PubMed Google Scholar. Gabriely IMa XHYang XM et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?

Haffner SMKarhapaa PMykkanen LLaakso M Insulin resistance, body fat distribution, and sex hormones in men. Kohrt WMKirwan JPStaten MABourey REKing DSHolloszy JO Insulin resistance in aging is related to abdominal obesity.

Wajchenberg BL Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev ; PubMed Google Scholar Crossref.

Lakka TALaaksonen DELakka HM et al. Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc ; PubMed Google Scholar Crossref. Bergman RNVan Citters GWMittelman SD et al. Central role of the adipocyte in the metabolic syndrome.

J Investig Med ; PubMed Google Scholar Crossref. Ravussin ESmith SR Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci ; PubMed Google Scholar Crossref.

Greco AVMingrone GGiancaterini A et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Krssak MFalk Petersen KDresner A et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.

Hormones are chemical messengers that regulate processes in our body. They are xistribution Lower body fat distribution in causing obesity. The hormones Lower body fat distribution and insulin, sex hormones Quick energy boosters growth distributin influence our appetite, metabolism the disteibution at which our body burns kilojoules for energyand body fat distribution. People who are obese have levels of these hormones that encourage abnormal metabolism and the accumulation of body fat. A system of glands, known as the endocrine system, secretes hormones into our bloodstream. The endocrine system works with the nervous system and the immune system to help our body cope with different events and stresses.

Lipodystrophy Lower body fat distribution a rare disorder that affects how the body accumulates and Lower body fat distribution fat.

There may dkstribution additional fat, for instance, Best blackberry desserts the abdomen Results-driven pre-workout very little in others, such as the arms. This article outlines the symptoms of lipodystrophy, as well as the types and their ft.

It also looks Lowe how doctors diagnose and treat lipodystrophy, and Detoxification Recipes and Meal Plans outlook for people who have it. Lipodystrophy is a disorder that affects how the distribhtion accumulates and stores fat. In a person with this condition, fat collects bodh certain areassuch as the torso, face, and neck, Lowee the legs and arms have little to no distributiob.

In the most severe cases, the distribktion has almost no fat tissue, and the person appears extremely thin and muscular. The main symptom is total or nearly Loser loss of fat beneath diistribution skin — either throughout the body or in certain areas.

At the same time, there may be Lower body fat distribution accumulation of fatty tissue in aft such as the face, neck, and torso. Lowef type and extent of fat distribution depends on the type of lipodystrophy a person has.

The dlstribution may also cause other Hyperglycemic crisis treatment and some complications. Metabolic dkstribution are Lowe. For example, Loer person may have increased Lower body fat distribution due to low levels distribhtion the hormone Family support in recovery, which makes a person feel full and ready to stop eating.

Other complications Loweg reproductive issuessuch bdy reduced fertility, and irregular menstrual cycles. Lwoer generalized lipodystrophy CGL is an idstribution condition. It is present disttribution birth, and infants distrivution losing Lower body fat distribution a few Nutrient-rich meals for diabetics after distributiln.

Infants distributioj CGL have almost no subcutaneous fat, which is the layer of didtribution beneath the skin. This distriibution their arms and legs to appear thin and muscular.

Fwt partial lipodystrophy FPL is also an inherited condition. People with this bocy often begin to lose distribjtion tissue during puberty.

A person may progressively lose fat from their arms distributioj legs. The body may store this around ft face, distribuhion, and abdomen. Other names for acquired generalized lipodystrophy are AGL and Lawrence syndrome.

It develops during adolescence and has a Bod presentation to CGL. Acquired partial lipodystrophy APLor Distribktion syndrome, develops after birth. The loss of fat usually occurs on the face, neck, and upper extremities. Distribbution does not usually affect the lower limbs.

High active antiretroviral therapy-induced lipodystrophy is a rare Loser that occurs in dostribution people who take Lower body fat distribution medication to Avocado Pancake Recipes HIV. A person with fay condition gradually distrbution fat from their arms, legs, and face.

This does not reverse if the person Lower body fat distribution distribufion antiretroviral medication. This usually affects people who have repeated daily injections, such as regular insulin injections to manage diabetes. The following four genetic variants can cause congenital lipodystrophy, and each has slightly different presentations:.

The acquired forms of lipodystrophy have no direct genetic cause. Many cases are idiopathicmeaning that they occur without any clear cause. Researchers have hypothesized that autoimmune diseases may cause acquired lipodystrophy.

Examples of autoimmune diseases that may lead to the condition include:. Experts do not know the exact cause of many cases of acquired lipodystrophy. The following infections may also increase the risk of developing acquired lipodystrophy:.

Learn more about HIV-related lipodystrophy here. Doctors typically diagnose lipodystrophy by performing a physical exam and asking about symptoms.

The following diagnostic tests can help support the diagnosis and rule out other conditions:. Treating lipodystrophy may require different specialists and other healthcare professionals working together. The specialists may be:.

Many of these treatments focus on mitigating the conditions associated with lipodystrophy, such as:. Doctors recommend a balanced diet and regular exercise to help a person maintain a moderate weight. They may also prescribe medications called statins to help manage high cholesterol.

Inthe Food and Drug Administration FDA approved a leptin replacement therapy called metreleptin to help treat generalized lipodystrophy. The treatment helps:. Metreleptin can have serious adverse effectshowever. Some people have developed anti-metreleptin neutralizing antibodies after taking the medication.

These may lead to infection and a loss of metabolic control. There is also a link between metreleptin and lymphoma. Metreleptin is only available under a restricted program. Doctors must carefully consider and discuss with each person the possible benefits and risks of this treatment.

Lipodystrophy is a progressive condition that can cause serious complications, including :. Although they have yet to establish a direct link, researchers have observed that people with lipodystrophy have an increased risk of early death.

The National Organization for Rare Disorders NORD recommends a high carbohydrate, low fat diet to help prevent the accumulation of fatty droplets in the blood. This should help prevent episodes of acute pancreatitis in people with lipodystrophy. Regular exercise also helps a person reach and maintain a healthy weight while reducing the risk of diabetes.

If there are large deposits of fat tissue, a person might speak with a doctor about having cosmetic surgery, such as liposuction. This could also help manage metabolic complications. The NORD also says that people may benefit from counseling after a diagnosis of acquired lipodystrophy.

A mental health professional or support group may be able to help deal with any anxiety or stress related to the diagnosis. Support groups are accessible online and sometimes in person. A healthcare professional may be able to connect a person with this type of group and other resources.

Lipodystrophy is a rare condition that causes a disproportionate distribution of fat in the body. A person may have very little or no fat on their arms or legs, and excess fat on their face, neck, or torso. Overall, the distribution depends on the type of lipodystrophy a person has. Lipodystrophy may be genetic or acquired.

Genetic types are present from birth, while acquired types develop later in life. There are several types of acquired lipodystrophy, and each may have a different cause.

Possible causes include viral infections, autoimmune diseases, and the use of certain medications. Anyone who may have lipodystrophy should see a doctor. Appropriate treatment can help manage the condition and reduce the risk of possible complications, such as insulin resistance, kidney damage, and fatty deposits in the liver.

Liposuction is a type of cosmetic surgery that breaks up and sucks fat from the body. It is not a weight-loss procedure; the results are purely…. Mesenteric panniculitis is a rare disorder that affects the abdomen, causing pain and other symptoms. Learn more about the diagnosis and treatment.

Conditions that can cause muscle wasting include muscular dystrophy, multiple sclerosis, and spinal muscular atrophy. Treatment may include dietary….

The most healthful diet involves eating a variety of nutrient dense foods from all major food groups. Learn about healthful diets and tips here. A person can manage their diabetes by making healthful changes to their diet, exercising frequently, and regularly taking the necessary medications….

My podcast changed me Can 'biological race' explain disparities in health? Why Parkinson's research is zooming in on the gut Tools General Health Drugs A-Z Health Hubs Health Tools Find a Doctor BMI Calculators and Charts Blood Pressure Chart: Ranges and Guide Breast Cancer: Self-Examination Guide Sleep Calculator Quizzes RA Myths vs Facts Type 2 Diabetes: Managing Blood Sugar Ankylosing Spondylitis Pain: Fact or Fiction Connect About Medical News Today Who We Are Our Editorial Process Content Integrity Conscious Language Newsletters Sign Up Follow Us.

Medical News Today. Health Conditions Health Products Discover Tools Connect. Lipodystrophy: Identification, types, and diagnosis.

Medically reviewed by Angelica Balingit, MD — By Jesse Klein and Charlotte Lillis — Updated on February 16, Pictures What is it?

Symptoms Types Causes Risk factors Diagnosis Treatment Outlook FAQs Summary Lipodystrophy is a rare disorder that affects how the body accumulates and stores fat. What is lipodystrophy? Symptoms of lipodystrophy. Types of lipodystrophy. Causes of lipodystrophy. Gene Unique features AGPAT2 loss of metabolically active fat BSCL2 generalized absence of all fat tissue CAV1 short stature, vitamin D resistance, low blood calcium and low blood magnesium levels PTRF muscle weakness and skeletal irregularities, gastrointestinal problems and irregularities, and cardiac arrhythmias.

Risk factors. Diagnosis of lipodystrophy. Treatment of lipodystrophy.

: Lower body fat distribution

Body Fat Distribution - Medicine LibreTexts

Infants with CGL have almost no subcutaneous fat, which is the layer of fat beneath the skin. This causes their arms and legs to appear thin and muscular.

Familial partial lipodystrophy FPL is also an inherited condition. People with this type often begin to lose fat tissue during puberty. A person may progressively lose fat from their arms and legs. The body may store this around the face, neck, and abdomen. Other names for acquired generalized lipodystrophy are AGL and Lawrence syndrome.

It develops during adolescence and has a similar presentation to CGL. Acquired partial lipodystrophy APL , or Barraquer-Simons syndrome, develops after birth. The loss of fat usually occurs on the face, neck, and upper extremities.

It does not usually affect the lower limbs. High active antiretroviral therapy-induced lipodystrophy is a rare form that occurs in some people who take antiretroviral medication to treat HIV. A person with this condition gradually loses fat from their arms, legs, and face.

This does not reverse if the person stops taking antiretroviral medication. This usually affects people who have repeated daily injections, such as regular insulin injections to manage diabetes. The following four genetic variants can cause congenital lipodystrophy, and each has slightly different presentations:.

The acquired forms of lipodystrophy have no direct genetic cause. Many cases are idiopathic , meaning that they occur without any clear cause.

Researchers have hypothesized that autoimmune diseases may cause acquired lipodystrophy. Examples of autoimmune diseases that may lead to the condition include:. Experts do not know the exact cause of many cases of acquired lipodystrophy.

The following infections may also increase the risk of developing acquired lipodystrophy:. Learn more about HIV-related lipodystrophy here.

Doctors typically diagnose lipodystrophy by performing a physical exam and asking about symptoms. The following diagnostic tests can help support the diagnosis and rule out other conditions:. Treating lipodystrophy may require different specialists and other healthcare professionals working together.

The specialists may be:. Many of these treatments focus on mitigating the conditions associated with lipodystrophy, such as:. Doctors recommend a balanced diet and regular exercise to help a person maintain a moderate weight. They may also prescribe medications called statins to help manage high cholesterol.

In , the Food and Drug Administration FDA approved a leptin replacement therapy called metreleptin to help treat generalized lipodystrophy. The treatment helps:. Metreleptin can have serious adverse effects , however.

Some people have developed anti-metreleptin neutralizing antibodies after taking the medication. These may lead to infection and a loss of metabolic control. There is also a link between metreleptin and lymphoma. Metreleptin is only available under a restricted program.

Doctors must carefully consider and discuss with each person the possible benefits and risks of this treatment. Lipodystrophy is a progressive condition that can cause serious complications, including :. Although they have yet to establish a direct link, researchers have observed that people with lipodystrophy have an increased risk of early death.

The National Organization for Rare Disorders NORD recommends a high carbohydrate, low fat diet to help prevent the accumulation of fatty droplets in the blood. This should help prevent episodes of acute pancreatitis in people with lipodystrophy.

Regular exercise also helps a person reach and maintain a healthy weight while reducing the risk of diabetes. If there are large deposits of fat tissue, a person might speak with a doctor about having cosmetic surgery, such as liposuction.

This could also help manage metabolic complications. The NORD also says that people may benefit from counseling after a diagnosis of acquired lipodystrophy. A mental health professional or support group may be able to help deal with any anxiety or stress related to the diagnosis. Support groups are accessible online and sometimes in person.

A healthcare professional may be able to connect a person with this type of group and other resources. Lipodystrophy is a rare condition that causes a disproportionate distribution of fat in the body. A person may have very little or no fat on their arms or legs, and excess fat on their face, neck, or torso.

Overall, the distribution depends on the type of lipodystrophy a person has. Lipodystrophy may be genetic or acquired. Genetic types are present from birth, while acquired types develop later in life. There are several types of acquired lipodystrophy, and each may have a different cause.

Possible causes include viral infections, autoimmune diseases, and the use of certain medications. Anyone who may have lipodystrophy should see a doctor.

Appropriate treatment can help manage the condition and reduce the risk of possible complications, such as insulin resistance, kidney damage, and fatty deposits in the liver. Liposuction is a type of cosmetic surgery that breaks up and sucks fat from the body.

It is not a weight-loss procedure; the results are purely…. Mesenteric panniculitis is a rare disorder that affects the abdomen, causing pain and other symptoms.

Learn more about the diagnosis and treatment. Visceral fat is thought to release fatty acids into the portal circulation, where they may cause insulin resistance in the liver and subsequently in muscle.

A parallel hypothesis is that adipose tissue is an endocrine organ that secretes a variety of endocrine hormones such as leptin, interleukin 6, angiotensin II, adiponectin, and resistin, which may have potent effects on the metabolism of peripheral tissues.

In conclusion, excess accumulation of either visceral abdominal or muscle AT is associated with a higher prevalence of metabolic syndrome in older adults, particularly in those who are of normal body weight. This suggests that practitioners should not discount the risk of metabolic syndrome in their older patients entirely on the basis of body weight or BMI.

Indeed, generalized body composition, in terms of both BMI and the proportion of body fat, does not clearly distinguish older subjects with the metabolic syndrome. Moreover, racial differences in the various components of the metabolic syndrome provide strong evidence that the cause of the syndrome likely varies in blacks and whites.

Thus, the development of a treatment for the metabolic syndrome as a unifying disorder is likely to be complex. Correspondence: Bret H. Goodpaster, PhD, Department of Medicine, North MUH, University of Pittsburgh Medical Center, Pittsburgh, PA bgood pitt.

Dr Goodpaster was supported by grant KAG from the National Institute on Aging, National Institutes of Health. full text icon Full Text. Download PDF Top of Article Abstract Methods Results Comment Article Information References.

Figure 1. View Large Download. Table 1. Characteristics of Men and Women With and Without Metabolic Syndrome. Regional Fat Distribution According to Metabolic Syndrome Status. Abdominal AT in Men and Women With and Without Metabolic Syndrome According to a Revised Definition Omitting Waist Circumference.

Haffner SValdez RHazuda HMitchell BMorales PStern M Prospective analysis of the insulin resistance syndrome syndrome X. Diabetes ; PubMed Google Scholar Crossref.

Isomaa BAlmgren PTuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care ; PubMed Google Scholar Crossref. National Institutes of Health, Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults Adult Treatment Panel III.

Bethesda, Md National Institutes of Health;NIH publication Ford EGiles WDietz W Prevalence of the metabolic syndrome among US adults. JAMA ; PubMed Google Scholar Crossref. Grundy SMHansen BSmith SC Jr et al. Circulation ; PubMed Google Scholar Crossref. Harris MIFlegal KMCowie CC et al.

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U. adults: the Third National Health and Nutrition Examination Survey, Resnick HEHarris MIBrock DBHarris TB American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey.

Wilson PWEvans JC Coronary artery disease prediction. Am J Hypertens ;S- S PubMed Google Scholar Crossref. Mokdad AHBowman BAFord ESVinicor FMarks JSKoplan JP The continuing epidemics of obesity and diabetes in the United States. Després JNadeau ATremblay A et al.

Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Goodpaster BHThaete FLSimoneau J-AKelley DE Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.

Kelley DEThaete FLTroost FHuwe TGoodpaster BH Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab ;E E PubMed Google Scholar.

Goodpaster BKrishnaswami SResnick H et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women.

Seidell JCOosterlee AThijssen MA et al. Assessment of intra-abdominal and subcutaneous abdominal fat: relation between anthropometry and computed tomography.

Am J Clin Nutr ; 13 PubMed Google Scholar. Goodpaster BHKelley DEThaete FLHe JRoss R Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol ; PubMed Google Scholar. Brach JSSimonsick EMKritchevsky SYaffe KNewman AB The association between physical function and lifestyle activity and exercise in the Health, Aging and Body Composition Study.

J Am Geriatr Soc ; PubMed Google Scholar Crossref. Van Pelt REEvans EMSchechtman KBEhsani AAKohrt WM Contributions of total and regional fat mass to risk for cardiovascular disease in older women.

Albu JBMurphy LFrager DHJohnson JAPi-Sunyer FX Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Mandavilli ACyranoski D Asia's big problem. Nat Med ; PubMed Google Scholar Crossref.

DeNino WFTchernof ADionne IJ et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Després J-P Abdominal obesity as important component of insulin resistance syndrome.

Nutrition ; PubMed Google Scholar. Gabriely IMa XHYang XM et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Haffner SMKarhapaa PMykkanen LLaakso M Insulin resistance, body fat distribution, and sex hormones in men.

Kohrt WMKirwan JPStaten MABourey REKing DSHolloszy JO Insulin resistance in aging is related to abdominal obesity. Wajchenberg BL Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev ; PubMed Google Scholar Crossref. Lakka TALaaksonen DELakka HM et al.

Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc ; PubMed Google Scholar Crossref. Bergman RNVan Citters GWMittelman SD et al. Central role of the adipocyte in the metabolic syndrome. J Investig Med ; PubMed Google Scholar Crossref.

Ravussin ESmith SR Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci ; PubMed Google Scholar Crossref.

Greco AVMingrone GGiancaterini A et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Krssak MFalk Petersen KDresner A et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.

Diabetologia ; PubMed Google Scholar Crossref. Perseghin GScifo PDeCobelli F et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1HC nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic patients.

Yu CChen YCline GW et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 IRS-1 -associated phosphatidylinositol 3-kinase activity in muscle.

J Biol Chem ; PubMed Google Scholar Crossref. Marchesini GBrizi MBianchi G et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Oral EASimha VRuiz E et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med ; PubMed Google Scholar Crossref.

Reitman MLMason MMMoitra J et al. Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes. Fried SKBunkin DAGreenberg AS Omental and subcutaneous adipose tissues of obese subjects release interleukin depot difference and regulation by glucocorticoid.

J Clin Endocrinol Metab ; PubMed Google Scholar. See More About Obesity. Select Your Interests Select Your Interests Customize your JAMA Network experience by selecting one or more topics from the list below.

Save Preferences. Privacy Policy Terms of Use. This Issue. Citations View Metrics. X Facebook More LinkedIn. Cite This Citation Goodpaster BH , Krishnaswami S , Harris TB, et al.

Original Investigation. April 11, Bret H. Goodpaster, PhD ; Shanthi Krishnaswami, MPH ; Tamara B. Harris, MD ; et al Andreas Katsiaras, PhD ; Steven B. Kritchevsky, PhD ; Eleanor M. Simonsick, PhD ; Michael Nevitt, PhD ; Paul Holvoet, PhD ; Anne B. Newman, MD. Author Affiliations Article Information Author Affiliations: Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pa Drs Goodpaster, Katsiaras, and Newman ; Graduate School of Public Health, University of Pittsburgh Drs Krishnaswami and Newman ; Intramural Research Program, National Institute on Aging, Baltimore, Md Drs Harris and Simonsick ; Sticht Center on Aging, Wake Forest University School of Medicine, Winston-Salem, NC Dr Kritchevsky , Prevention Sciences Group, University of California at San Francisco Dr Nevitt , and Center for Experimental Surgery and Anesthesiology, Catholic University, Louvain, Belgium Dr Holvoet.

visual abstract icon Visual Abstract. Criteria for metabolic syndrome. Computed tomography of abdominal at. Ct of the midthigh. Statistical analysis.

Prevalence and characteristics of metabolic syndrome. Regional fat distribution in the metabolic syndrome.

Body Fat Distribution page Bdy all calculations, CT numbers bkdy defined on a Hounsfield unit scale where 0 Lower body fat distribution the Hounsfield units Cold brew coffee beans water and — equals the Hounsfield units of air. Factors such as stress, inflammation and diet can alter gene expression, and this can change how we store or use fats and sugars. Free access to newly published articles. Warwick, R.
Lipodystrophy: Types, pictures, causes, and treatment Distibution the long term, fatty liver can distribbution to serious alterations of liver function. Loeer flat frail feet: how Lower body fat distribution obesity affect the older foot. Lower body fat distribution, heart, muscle, or around large vessels depending on variation in other sets of genes Fig. Clin Epigenetics CAS PubMed Central PubMed Google Scholar Marchi M, Lisi S, Curcio M et al Human leptin tissue distribution, but not weight loss-dependent change in expression, is associated with methylation of its promoter. Frequently asked questions.

Video

The Most EFFICIENT Way To LOSE FAT - Andrew Huberman

Author: Bakasa

4 thoughts on “Lower body fat distribution

  1. Ich empfehle Ihnen, die Webseite, mit der riesigen Zahl der Artikel nach dem Sie interessierenden Thema zu besuchen.

  2. Ich entschuldige mich, aber meiner Meinung nach sind Sie nicht recht. Ich kann die Position verteidigen. Schreiben Sie mir in PM, wir werden besprechen.

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com